DiaMedica Therapeutics (DMAC) Change in Cash (2018 - 2026)
DiaMedica Therapeutics (DMAC) posted quarterly Change in Cash of -$10.8 million for Q1 2026, down 2372.25% year-over-year from $474376.1 in Q1 2025, and down 187.48% quarter-over-quarter from $12.3 million in Q4 2025.
DiaMedica Therapeutics (DMAC) Change in Cash (2018 - 2026) Analysis & Trends
DiaMedica Therapeutics' Change in Cash history runs 9 years deep, the most recent figure standing at -$10.8 million for Q1 2026.
- In Q1 2026, Change in Cash fell 2372.25% year-over-year to -$10.8 million; the TTM figure through Mar 2026 stood at $2.3 million (up 363.21% YoY), while the FY2025 annual figure was $12.6 million, up 931.49% from the prior year.
- Change in Cash for Q1 2026 stood at -$10.8 million, down from $12.3 million in the prior quarter.
- The five-year high for Change in Cash was $12.3 million in Q4 2025, with the low at -$10.8 million in Q1 2026.
- The 5-year median for Change in Cash is -$436000.0 (2025), against an average of $9470.6.
- The sharpest annual moves came in 2023 and 2026: Change in Cash soared 12206.67% in 2023, then slumped 2372.25% in 2026.
- DiaMedica Therapeutics' Change in Cash stood at $2.0 million in 2022, then advanced by 18.09% to $2.3 million in 2023, then sank by 147.99% to -$1.1 million in 2024, then jumped by 1211.0% to $12.3 million in 2025, then slumped by 187.48% to -$10.8 million in 2026.
- Business Quant data shows DMAC's Change in Cash at -$10.8 million in Q1 2026, $12.3 million in Q4 2025, and -$783000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 649.20 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | -504.60 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 374.50 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 427.25 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -1.97 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 225.59 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | -2.94 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -37.42 Mn |
| 10 | DiaMedica Therapeutics | 360.22 Mn | 360.22 Mn | - | 261,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 261,000.00 |
| Mar 31, 2026 | -10.78 Mn |
| Dec 31, 2025 | 12.32 Mn |
| Sep 30, 2025 | -783,000.00 |
| Jun 30, 2025 | 1.52 Mn |
| Mar 31, 2025 | -436,000.00 |
| Dec 31, 2024 | -1.11 Mn |
| Sep 30, 2024 | -9.93 Mn |
| Jun 30, 2024 | 11.97 Mn |
| Mar 31, 2024 | -2.45 Mn |
| Dec 31, 2023 | 2.31 Mn |
| Sep 30, 2023 | -3.61 Mn |
| Jun 30, 2023 | 3.69 Mn |
| Mar 31, 2023 | -2.58 Mn |
| Dec 31, 2022 | 1.96 Mn |
| Sep 30, 2022 | -291,000.00 |
| Jun 30, 2022 | 30,000.00 |
| Mar 31, 2022 | -1.68 Mn |
| Dec 31, 2021 | -11.51 Mn |
| Sep 30, 2021 | 13.99 Mn |